SS-31: Mechanistic Overview
internal_protocol · preclinical · status: needs_provider_review
Metadata
Author: Axiom Knowledge Base
Citation: Internal reference summary compiled for the Axiom knowledge base (2026).
Embedding: pending
File: signed link
Summary (generated — provider review required)
SS-31 (elamipretide) is a mitochondria-targeting tetrapeptide that binds cardiolipin on the inner mitochondrial membrane. Mechanism: stabilizes cristae structure and improves electron-transport efficiency, reducing reactive oxygen species in models of mitochondrial dysfunction; studied in clinical trials for primary mitochondrial myopathy. Relevance: mitochondrial/fatigue phenotypes.
The original source document remains the source of truth. Generated summaries are not authoritative.
Linked assets (3) · phenotypes (1)
evidence_reference, safety_reference, dosing_reference
Phenotypes: mitochondrial_dysfunction
Evidence claims (3) · review items (2)
outcome · pending
Mechanism: stabilizes cristae structure and improves electron-transport efficiency, reducing reactive oxygen species in models of mitochondrial dysfunction; studied in clinical trials for primary mitochondrial myopathy.
safety · pending
Safety: investigational.
dosing · pending
Mechanistic background for provider review only — not a treatment recommendation or dosing guidance.
Extracted chunks (1)
58 approx tokens across 1 chunks.